TRAVERE THERAPEUTICS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+1.9% +$11M
$605M
Current Assets↑+5.0% +$21M
$438M
Cash & Equivalents↑+58.9% +$35M
$93M
ST Investments
—
Receivables↑+195.5% +$53M
$80M
Inventory↓-13.6% -$6M
$36M
Net PPE↓-24.6% -$1M
$4M
Goodwill↑+0.0% +$0
$800K
Intangibles↑+9.5% +$10M
$114M
Total Liabilities↓-8.4% -$45M
$490M
Current Liabilities↓-20.3% -$41M
$160M
Account Payables↑+5.4% +$1M
$25M
Long-Term Debt
—
Stockholders Equity↑+94.4% +$56M
$115M
Retained Earnings↓-1.8% -$26M
$-1.47B
Operating Lease ROU Asset↓-26.0% -$4M
$11M
Operating Lease Liability↓-1.1% -$182K
$17M
Gross PP&E↑+0.2% +$29K
$14M
Accumulated Depreciation↑+15.3% +$1M
$10M
Inventory Raw Materials↓-20.9% -$6M
$24M
Inventory WIP↓-69.2% -$5M
$2M
Inventory Finished Goods↑+162.0% +$6M
$10M
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
—
Debt Due Y5
—
Debt Due >Y5
—
Total Debt Carrying Amount
—
Contract Liability↓-100.0% -$3M
$0
Contract Liability (Current)
$3M
Contract Liability (Noncurrent)
$0